Skip to main content
logo
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.080
+0.380 (10.27%)
Aug 27, 2026, 4:08 PM HKT

HKG:1541 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,5972,5162,10211,187--
Market Cap Growth
-68.21%19.70%-81.21%---
Enterprise Value
9081,9121,65510,650--
Last Close Price
3.705.835.1629.90--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.9814.6526.641319.67--
PB Ratio
2.222.862.9113.57--
P/TBV Ratio
2.212.862.9113.57--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.2411.1420.981256.23--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.570.290.200.100.02-0.01
Net Debt / Equity Ratio
-0.95-1.00-0.91-0.71-0.800.41
Net Debt / EBITDA Ratio
2.633.672.031.521.763.21
Net Debt / FCF Ratio
-3.874.451.442.372.81
Asset Turnover
0.140.150.080.010.01-
Inventory Turnover
-0.04----
Quick Ratio
2.543.743.515.2612.300.27
Current Ratio
2.663.844.045.9312.600.28
Return on Equity (ROE)
-40.11%-29.87%-44.38%-49.68%--
Return on Assets (ROA)
-16.24%-13.80%-21.81%-26.59%-26.29%-
Return on Capital Employed (ROCE)
-35.60%-27.10%-44.30%-48.10%-46.20%13.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.64%-9.67%-15.99%-3.74%--
FCF Yield
--9.02%-7.01%-3.65%--
Buyback Yield / Dilution
-7.25%-9.35%-4.24%-9.05%-284.99%-